Literature DB >> 1713249

Abnormal thymic development, impaired immune function and gamma delta T cell lymphomas in a TL transgenic mouse strain.

Y Obata1, O Taguchi, Y Matsudaira, H Hasegawa, N Hamasima, T Takahashi.   

Abstract

During derivation of transgenic mouse strains with various TL and TL/H-2 chimeric genes, one strain, Tg.Tlaa-3-1, introduced with a TL gene (Tlaa-3), was found to have an abnormal thymic T cell population and to develop a high incidence of T cell lymphomas. To investigate the etiology of the thymic abnormalities and of the lymphomas, the development of lymphoid organs in transgenic mice was studied. The thymus of these mice goes through three unusual successive events: perturbation of thymic development during embryogenesis, disappearance of thymocytes between day 14 and day 21 after birth, and subsequent proliferation of large blast-like cells. These events are associated with the abolishment of T cell receptor (TCR) alpha beta lineage of the T cell differentiation, leading to preponderance of cells belonging to the TCR gamma delta L3T4-Lyt-2- double negative (DN) lineage. Bone marrow transplantation and thymic graft experiments demonstrate that the abnormality resides in the bone marrow stem cells rather than in the thymic environment. The expression of TL antigen in the transgenic mice is greatly increased and TL is expressed in a wide range of T cells, including normally TL- DN cells and L3T4+ Lyt-2- and L3T4-Lyt-2+ single positive cells. These quantitative and qualitative abnormalities in TL expression most likely cause the abnormal T cell differentiation. The gamma delta DN cells migrate into peripheral lymphoid organs and constitute nearly 50% of peripheral T cells. Immune function of the transgenic mice is severely impaired, as T cell function is defective in antibody production to sheep red blood cells, in mixed lymphocyte culture reaction to allogenic spleen cells and also in stimulation with concanavalin A. These results indicate that the gamma delta cells are incapable of participating in these reactions. Molecular and serological analysis of T cell lymphomas reveal that they belong to the gamma delta lineage, suggesting that the gamma delta DN cells in this strain are susceptible to leukemic transformation. Based on cell surface phenotype and TCR expression of the DN thymocytes and T cell lymphomas, a map of the sequential steps involved in the differentiation of gamma delta DN cells is proposed.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1713249      PMCID: PMC2118907          DOI: 10.1084/jem.174.2.351

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

1.  Expression of the thymus leukemia antigen in mouse intestinal epithelium.

Authors:  R Hershberg; P Eghtesady; B Sydora; K Brorson; H Cheroutre; R Modlin; M Kronenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

2.  ANTIGENIC PROPERTIES OF EXPERIMENTAL LEUKEMIAS. I. SEROLOGICAL STUDIES IN VITRO WITH SPONTANEOUS AND RADIATION-INDUCED LEUKEMIAS.

Authors:  L J OLD; E A BOYSE
Journal:  J Natl Cancer Inst       Date:  1963-10       Impact factor: 13.506

3.  Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms.

Authors:  T B DUNN
Journal:  J Natl Cancer Inst       Date:  1954-06       Impact factor: 13.506

4.  Influence of 5' flanking sequences on TL and H-2 expression in transfected L cells.

Authors:  Y Obata; E Stockert; Y T Chen; T Takahashi; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

5.  Characterization of a monoclonal antibody which detects all murine alpha beta T cell receptors.

Authors:  R T Kubo; W Born; J W Kappler; P Marrack; M Pigeon
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

6.  Identification of a monoclonal antibody specific for a murine T3 polypeptide.

Authors:  O Leo; M Foo; D H Sachs; L E Samelson; J A Bluestone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

7.  "Radioresistant" intrathymic T cell precursors express T cell receptor C gamma 4- and C delta-specific gene messages.

Authors:  K Kishihara; Y Yoshikai; G Matsuzaki; S Tomooka; K Nomoto
Journal:  Eur J Immunol       Date:  1988-06       Impact factor: 5.532

8.  Rearrangement of T-cell delta locus in lymphoproliferative disorders.

Authors:  D C Tkachuk; H Griesser; Y Takihara; E Champagne; M Minden; A C Feller; K Lennert; T W Mak
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

Review 9.  Recognition of MHC TL gene products by gamma delta T cells.

Authors:  L Van Kaer; M Wu; Y Ichikawa; K Ito; M Bonneville; S Ostrand-Rosenberg; D B Murphy; S Tonegawa
Journal:  Immunol Rev       Date:  1991-04       Impact factor: 12.988

10.  Structure and specificity of T cell receptor gamma/delta on major histocompatibility complex antigen-specific CD3+, CD4-, CD8- T lymphocytes.

Authors:  J A Bluestone; R Q Cron; M Cotterman; B A Houlden; L A Matis
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  4 in total

1.  Expression of the Q2 gene of the MHC in thymus and intestinal epithelial cells.

Authors:  Q Wang; J Geliebter; S Tonkonogy; L Flaherty
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  Structure, function, and evolution of mouse TL genes, nonclassical class I genes of the major histocompatibility complex.

Authors:  Y Obata; Y Satta; K Moriwaki; T Shiroishi; H Hasegawa; T Takahashi; N Takahata
Journal:  Proc Natl Acad Sci U S A       Date:  1994-07-05       Impact factor: 11.205

3.  Positive selection of gamma delta CTL by TL antigen expressed in the thymus.

Authors:  K Tsujimura; T Takahashi; A Morita; H Hasegawa-Nishiwaki; S Iwase; Y Obata
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

4.  TL antigen as a transplantation antigen recognized by TL-restricted cytotoxic T cells.

Authors:  A Morita; T Takahashi; E Stockert; E Nakayama; T Tsuji; Y Matsudaira; L J Old; Y Obata
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.